Paying for Outcomes in Medicine:
A Win for Patients
Increasingly, biopharmaceutical companies are entering into risk-based
payment arrangements with payers for medicines. Under these
arrangements, payers often pay a variable rate depending on how well a
medicine works for the intended patient. For patients, these
arrangements can offer important benefits -- medicines that work best
for them and, often, reduced patient costs.